Element Capital Management LLC purchased a new position in shares of Humana (NYSE:HUM) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 81,545 shares of the insurance provider’s stock, valued at approximately $20,229,000. Element Capital Management LLC owned about 0.06% of Humana at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in HUM. Janus Henderson Group PLC increased its holdings in shares of Humana by 74.1% during the 3rd quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock worth $664,921,000 after buying an additional 1,161,661 shares during the last quarter. APG Asset Management N.V. increased its holdings in shares of Humana by 60.3% during the 4th quarter. APG Asset Management N.V. now owns 729,519 shares of the insurance provider’s stock worth $150,709,000 after buying an additional 274,435 shares during the last quarter. Bank of Montreal Can increased its holdings in shares of Humana by 118.3% during the 4th quarter. Bank of Montreal Can now owns 501,379 shares of the insurance provider’s stock worth $124,378,000 after buying an additional 271,701 shares during the last quarter. Virtus Fund Advisers LLC increased its holdings in Humana by 116.8% in the 4th quarter. Virtus Fund Advisers LLC now owns 423,275 shares of the insurance provider’s stock valued at $105,171,000 after purchasing an additional 228,050 shares during the last quarter. Finally, Hudson Bay Capital Management LP increased its holdings in Humana by 785.6% in the 4th quarter. Hudson Bay Capital Management LP now owns 221,398 shares of the insurance provider’s stock valued at $54,922,000 after purchasing an additional 196,398 shares during the last quarter. Institutional investors and hedge funds own 96.38% of the company’s stock.
In related news, insider M Todoroff Christopher sold 16,389 shares of the business’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $273.37, for a total value of $4,480,260.93. Following the completion of the sale, the insider now directly owns 13,447 shares of the company’s stock, valued at $3,676,006.39. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Bruce D. Broussard sold 14,075 shares of the business’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $274.32, for a total transaction of $3,861,054.00. Following the completion of the sale, the chief executive officer now directly owns 113,896 shares of the company’s stock, valued at $31,243,950.72. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 31,660 shares of company stock valued at $8,668,218. Corporate insiders own 0.60% of the company’s stock.
HUM has been the subject of several research reports. Zacks Investment Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Friday, January 19th. Cowen reiterated a “buy” rating and issued a $285.00 target price on shares of Humana in a report on Wednesday, December 13th. Jefferies Group upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $221.00 target price for the company in a report on Friday, January 12th. Oppenheimer lifted their target price on shares of Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a report on Thursday, February 8th. Finally, Leerink Swann lifted their target price on shares of Humana from $280.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 8th. Seven research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $272.21.
Shares of Humana stock traded down $3.56 during trading on Friday, hitting $283.73. 697,914 shares of the stock were exchanged, compared to its average volume of 1,120,478. The stock has a market cap of $39,065.09, a P/E ratio of 24.23, a price-to-earnings-growth ratio of 1.54 and a beta of 0.97. Humana has a 12-month low of $209.91 and a 12-month high of $293.35. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.48.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.06. The business had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same period in the previous year, the company earned $2.34 EPS. sell-side analysts forecast that Humana will post 13.84 earnings per share for the current fiscal year.
Humana announced that its Board of Directors has authorized a share repurchase plan on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the insurance provider to purchase shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s board of directors believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be given a dividend of $0.50 per share. This is a boost from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Wednesday, March 28th. Humana’s payout ratio is 17.08%.
WARNING: “Element Capital Management LLC Takes Position in Humana (HUM)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/04/08/81545-shares-in-humana-inc-hum-acquired-by-element-capital-management-llc.html.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.